Search details
1.
MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer: Final Results from a 2-year Phase II Clinical Trial.
Radiology
; 310(3): e231473, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38441092
2.
New Prostate MRI Scoring Systems (PI-QUAL, PRECISE, PI-RR, and PI-FAB): AJR Expert Panel Narrative Review.
AJR Am J Roentgenol
; 2024 Apr 03.
Article
in English
| MEDLINE | ID: mdl-38568038
3.
MRI-guided Minimally Invasive Focal Therapies for Prostate Cancer.
Radiology
; 309(3): e230431, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-38051187
4.
The role of [18F]-DCFPyL PET/MRI radiomics for pathological grade group prediction in prostate cancer.
Eur J Nucl Med Mol Imaging
; 50(7): 2167-2176, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36809425
5.
PI-RR: The Prostate Imaging for Recurrence Reporting System for MRI Assessment of Local Prostate Cancer Recurrence After Radiation Therapy or Radical Prostatectomy-A Review.
AJR Am J Roentgenol
; 220(6): 852-861, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36722763
6.
Comparison of Micro-US and Multiparametric MRI for Prostate Cancer Detection in Biopsy-Naive Men.
Radiology
; 305(2): 390-398, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35852425
7.
Prostate biopsy in the era of MRI-targeting: towards a judicious use of additional systematic biopsy.
Eur Radiol
; 32(11): 7544-7554, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-35507051
8.
Exploring the value of using patient-oriented MRI reports in clinical practice - a pilot study.
Support Care Cancer
; 30(8): 6857-6876, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-35534628
9.
Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer.
Radiology
; 300(2): 369-379, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34032510
10.
MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial.
Radiology
; 298(3): 695-703, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33529137
11.
Detection of clinically significant prostate cancer with 18F-DCFPyL PET/multiparametric MR.
Eur J Nucl Med Mol Imaging
; 48(11): 3702-3711, 2021 10.
Article
in English
| MEDLINE | ID: mdl-33846845
12.
Research biopsies in patients with gynecologic cancers: patient-reported outcomes, perceptions, and preferences.
Am J Obstet Gynecol
; 225(6): 658.e1-658.e9, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34174204
13.
Advanced ultrasound in the diagnosis of prostate cancer.
World J Urol
; 39(3): 661-676, 2021 Mar.
Article
in English
| MEDLINE | ID: mdl-32306060
14.
MRI Targeted Prostate Biopsy Techniques: AJR Expert Panel Narrative Review.
AJR Am J Roentgenol
; 217(6): 1263-1281, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34259038
15.
Quantitative Prostate MRI Analysis Following Fluvastatin Therapy for Localized Prostate Cancer - A Pilot Study.
Can Assoc Radiol J
; 72(4): 750-758, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-33563030
16.
Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel.
Radiology
; 296(1): 76-84, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32315265
17.
Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?
J Urol
; 204(6): 1187-1194, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32496160
18.
Negative Predictive Value of Prostate Multiparametric Magnetic Resonance Imaging among Men with Negative Prostate Biopsy and Elevated Prostate Specific Antigen: A Clinical Outcome Retrospective Cohort Study.
J Urol
; 202(6): 1159-1165, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31188731
19.
Corrigendum to Research biopsies in patients with gynecologic cancers: patient-reported outcomes, perceptions, and preferences: Am J Obstet Gynecol 225 (2021) 658.e1-658.e9/Article 658.
Am J Obstet Gynecol
; 231(1): 141, 2024 Jul.
Article
in English
| MEDLINE | ID: mdl-38679558
20.
Ablation energies for focal treatment of prostate cancer.
World J Urol
; 37(3): 409-418, 2019 Mar.
Article
in English
| MEDLINE | ID: mdl-29943219